This company is no longer active
Diffusion Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Diffusion Pharmaceuticals has a total shareholder equity of $14.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.7M and $1.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$15.00m |
| Equity | US$14.23m |
| Total liabilities | US$1.46m |
| Total assets | US$15.69m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DP80's short term assets ($15.7M) exceed its short term liabilities ($1.5M).
Long Term Liabilities: DP80 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DP80 is debt free.
Reducing Debt: DP80 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DP80 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: DP80 has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 6.4% each year.